Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Fragulidis

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Transplantation|December 30, 1998
In situ enzymatic oligonucleotide amplification of hepatitis C virus-RNA in liver biopsy specimens (reverse transcriptase in situ polymerase chain reaction) after orthotopic liver transplantation for hepatitis C-related liver diseaseG P Fragulidis, R E Cirocco, D Weppler, et al.
Transplantation Proceedings|June 24, 1998
Comparison of tacrolimus with neoral as primary immunosuppression in hepatitis C patients after liver transplantationX A Zervos, D Weppler, G P Fragulidis, et al.
Transplantation|May 16, 1998
Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantationX A Zervos, D Weppler, G P Fragulidis, et al.
Transplantation Proceedings|November 20, 1997
Recurrent hepatitis C infection following orthotopic liver transplantation is predicted by posttransplant serum and hepatic allograft viral titersR Cirocco, G P Fragulidis, D Weppler, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Transplantation|December 30, 1998
In situ enzymatic oligonucleotide amplification of hepatitis C virus-RNA in liver biopsy specimens (reverse transcriptase in situ polymerase chain reaction) after orthotopic liver transplantation for hepatitis C-related liver diseaseG P Fragulidis, R E Cirocco, D Weppler, et al.
Transplantation Proceedings|June 24, 1998
Comparison of tacrolimus with neoral as primary immunosuppression in hepatitis C patients after liver transplantationX A Zervos, D Weppler, G P Fragulidis, et al.
Transplantation|May 16, 1998
Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantationX A Zervos, D Weppler, G P Fragulidis, et al.
Transplantation Proceedings|November 20, 1997
Recurrent hepatitis C infection following orthotopic liver transplantation is predicted by posttransplant serum and hepatic allograft viral titersR Cirocco, G P Fragulidis, D Weppler, et al.
Pageof 2